Table 3 Outcome of renal cell carcinoma patients with and without cerebral metastasis
| Â | All patients n = 109 n | % | Patients without BM n = 97 n | % | Patients with BM n = 12 n | % |
|---|---|---|---|---|---|---|
Best response to TA | Â | Â | Â | Â | Â | Â |
   - CR | 6 | 5.5 | 5 | 5.2 | 1 | 8.3 |
   - PR | 27 | 24.8 | 25 | 25.8 | 2 | 16.7 |
   - SD | 61 | 56 | 54 | 55.7 | 7 | 58.3 |
   - PD | 15 | 13.8 | 13 | 13,4 | 2 | 16.7 |
| Â | All patients n = 114 median (months) | 95%CI | Patients without BM n= 102 median (months) | 95% CI | Patients with BM n = 12 median (months) | 95% CI |
Progression free survival (start first TA- progression) | 10.9 | 8.3-13.5 | 11.4 | 8.7-14.1 | 8.7 | 5.1-12.3 |
Overall survival (start first TA- death) | 33.3 | 19.3-47.2 | 33.3 | 18.6-47.9 | 13.4 | 1-43.9 |